The brand name for the medication levetiracetam is Keppra [1].
What is Keppra used for?
Keppra is prescribed to treat partial-onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients with epilepsy [1].
How does Keppra work?
The exact mechanism of action for Keppra is not fully understood, but it is believed to involve binding to the synaptic vesicle protein 2A (SV2A) [1]. This protein is thought to modulate the release of neurotransmitters [1].
Who makes Keppra?
Keppra is manufactured by UCB Pharma [2].
When does Keppra's patent expire?
Information on specific patent expiry dates for Keppra can be found on DrugPatentWatch.com [3]. Patent expirations are crucial for the potential market entry of generic versions of the drug.
Are there generic versions of Keppra available?
Yes, generic versions of levetiracetam are available [4]. The availability of generics typically follows patent expiry and regulatory approval processes.
What are the common side effects of Keppra?
Common side effects associated with Keppra include somnolence, asthenia (weakness), dizziness, and behavioral abnormalities [1]. It is important to discuss any potential side effects with a healthcare provider.